SCHEMBL4728987

SCHEMBL4728987

Cc1c[c]c(S(C)(=O)=O)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.36
CA1 P00915 5/20 0.33
CA2 P00918 5/20 0.33
CA9 Q16790 3/20 0.33
CA12 O43570 1/20 0.33
CA3 P07451 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
PTGS2 P35354 5/20 0.32
TLR9 Q9NR96 1/20 0.32
ALDH1A1 P00352 4/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
ACHE P22303 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
MMP1 P03956 1/20 0.30
MMP2 P08253 1/20 0.30
MMP9 P14780 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7047732 0.80 GAA (0.34) GAACA1CA2CA9CA12
SCHEMBL3066974 0.77 ENPP2 (0.43) PTGS2SMN1; SMN2
SCHEMBL18230176 0.76 L3MBTL1 (0.39) GAACA1CA2CA9CA12
SCHEMBL18230264 0.76 PLCG1 (0.33) CA2PTGS2
SCHEMBL1197147 0.76 PTGS2 (0.36) CA1CA2CA9CA12CA3
SCHEMBL6958683 0.71 PTGS2 (0.39) CA1CA2CA9CA12CA3
SCHEMBL18229988 0.70 CA2 (0.41) CA1CA2CA9CA12ALDH1A1
SCHEMBL6963062 0.70 CA1 (0.42) CA1CA2CA9CA12CA3
SCHEMBL2188402 0.70 KIF11 (0.46) PTGS2ALDH1A1CYP3A4PTGS1
SCHEMBL22804 0.68 CA1 (0.36) GAACA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1907376-A2 STEREOISOMERIC PYRIDYL AND PYRIDONYL COMPOUNDS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS Aryx Therapeutics, Inc. (US) 2008-04-09 EP disclosed
WO-2007005951-A2 STEREOISOMERIC PYRIDYL AND PYRIDONYL COMPOUNDS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS ARYX THERAPEUTICS, INC. (US) 2007-01-11 WO disclosed